Rani Therapeutics Holdings (RANI) Receivables - Accured (2022 - 2023)

Rani Therapeutics Holdings' (RANI) quarterly Receivables - Accured came in at $200000.0 in Q4 2023, little changed year-on-year from $200000.0 in Q4 2022, and little changed quarter-over-quarter from $200000.0 in Q3 2023.

Rani Therapeutics Holdings (RANI) Receivables - Accured (2022 - 2023) Analysis & Trends

Rani Therapeutics Holdings' Receivables - Accured history runs 2 years deep, the most recent figure standing at $200000.0 for Q4 2023.

  • On a quarterly basis, Receivables - Accured changed 0.0% year-over-year to $200000.0 in Q4 2023; TTM through Dec 2023 was $200000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $200000.0, changed 0.0% from the prior year.
  • Receivables - Accured steadied at $200000.0 in Q4 2023 per RANI's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Receivables - Accured topped out at $200000.0 in Q4 2022 and bottomed at $100000.0 in Q1 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Rani Therapeutics Holdings 160.20 Mn 167.33 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 200,000.00
Dec 31, 2023 200,000.00
Sep 30, 2023 200,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 100,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 200,000.00
Dec 31, 2022 200,000.00